Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile

Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
58 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The companys products include acetaldehyde binding products, diagnostic tests, monoclonal antibodies, laboratory instruments and pipettes. It targets therapeutic areas of gastric cancer, gastroesophageal reflux disease (GERD) and colorectal cancer and others. Biohits laboratory equipment comprise microplate instruments, automates and liquid handling products to support Biohit ELISA tests. The company also offers tests for the diagnosis of lactose intolerance and helicobacter pylori infection.

Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal r

  
Source:
Document ID
GDME80D
Country
Industry
Ticker
BIOBV=FI
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
Biohit Oyj, Medical Equipment, Deals By Year, 2010 to YTD 201652
Biohit Oyj, Medical Equipment Deals By Type, 2010 to YTD 201671
Biohit Oyj, Medical Equipment, Deals By Region, 2010 to YTD 201681
Biohit Oyj, Medical Equipment, Deals By Market, 2010 to YTD 201691
Biohit Oyj, Medical Equipment, Deals Summary, 2010 to YTD 2016101
Biohit Oyj, Medical Equipment, Deal Details1114
  Asset Purchase111
    Biohit Acquires Rights To UFT300 Test From Advanced Biomedical Systems For US$0.5 Million111
  Partnerships121
    Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test121
    Biohit Enters into Distribution Agreement with Pooyandegan Pezeshki Pardis131
    Biohit Enters into Distribution Agreement with Genetic Analysis141
    Biohit Enters Into Distribution Agreement With Dynex Technologies151
    Biohit Forms Joint Venture with Anhui Wisdom-Win Investment161
    Ferring Pharma Enters Into Distribution Agreement With Biohit Healthcare For PreventID CalScreen171
    Biohit Enters Into Distribution Agreement With IBL International For GastroPanel181
    Biohit Enters Into Distribution Agreement With Hefei Medicine For GastroPanel Test191
    Biohit Enters Into Distribution Agreement With Fisher Scientific For Diagnostic Products201
    Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel211
  Debt Offering221
    Biohit Completes Private Placement of 6.5% Convertible Bonds Due 2015 for USD5.3 Million221
  Acquisition231
    Biohit Acquires 18% Stake in Genetic Analysis231
    Biohit Completes Acquisition of Euroclone Gastro from Euroclone for USD1.48 Million241
Biohit Oyj - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
  Other Locations &Subsidiaries271
Recent Developments281
Financial Announcements281
Aug 18, 2016: Biohit Group Half Year Financial report 20162814
Aug 20, 2015: Biohit Group Interim Report Q2/2015425
May 07, 2015: Biohit Group interim report Q1-2015472
Feb 26, 2015: Biohit Group Financial Statement Release 2014493
Corporate Communications521
Aug 26, 2016: Ilari Patrakka appointed Biohit Oyj s Sales and Marketing Director521
Government and Public Interest531
Apr 15, 2015: Recommendations for detection of gastric cancer risk and monitoring of the cancer precursors531
Product News541
Feb 20, 2015: BIOHIT ColonView is the best colorectal cancer screening test on the market541
Other Significant Developments551
May 04, 2015: Mekalasi Oy to distribute Biohit Quick Tests in Finland551
Mar 23, 2015: Biohit and Gulf Drug to sign a distributor agreement561
Jan 29, 2015: Biohit and Ympyratalo Pharmacy to co-operation571
Appendix581
  Methodology581
  About GlobalData581
  Contact Us581
  Disclaimer581

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. May 04, 2025. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Biohit-Oyj-BIOBV-Medical-Equipment-Deals-and-Alliances-Profile-2148-17520>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Biohit-Oyj-BIOBV-Medical-Equipment-Deals-and-Alliances-Profile-2148-17520>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research